Skip to main content

Security report for sbd.ee

Solis BioDyne OÜ · Healthcare · Estonia

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 2 other checks.

Security score

57/100

Risk levelMedium

0–100, higher is better. How it is calculated

Solis BioDyne OÜ is an established Estonian company specializing in the development and production of molecular biology reagents, particularly PCR, qPCR, and RT-qPCR products. Founded in 1995, it has grown into a leading reagent supplier in Europe with a global customer base including research institutes and biotech companies. The company offers a broad product portfolio and additional services such as contract manufacturing and assay development. The website reflects a professional and comprehensive digital presence with clear product information, customer testimonials, and certifications that reinforce its market position. Technically, the site uses modern web technologies including jQuery, Bootstrap, Google Tag Manager, and reCAPTCHA, ensuring a responsive and user-friendly experience. Security posture is good with HTTPS, cookie consent, and no visible vulnerabilities, although DNSSEC is not enabled and some security headers could be improved. Privacy compliance is well addressed with clear policies and GDPR adherence. Overall, the domain registration data aligns well with the business claims, supporting legitimacy and trustworthiness.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching sbd.ee

This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
15
Email security
85
DNS health
85
Network security
20
GDPR outside view
73
Average
57

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates a B2B business model focused on supplying high-quality life science reagents to research and biotech sectors. Its competitive advantages include product stability at room temperature, ISO certifications, and a flexible service offering including custom formulations and white labeling. The presence of global partners and testimonials indicates a strong partnership ecosystem and growing market presence. The company targets scientific institutions and biotech firms requiring reliable molecular biology reagents. Growth indicators include active news updates, product launches, and educational outreach such as genetic workshops. The website's multilingual support and e-shop functionality further support its commercial operations.

Security posture

Solis BioDyne demonstrates a mature security posture with HTTPS enforced, use of Google reCAPTCHA v3 to protect forms, and a cookie consent mechanism. The domain is protected with clientTransferProhibited status, reducing risk of unauthorized transfers. However, DNSSEC is not enabled, which is a recommended improvement for DNS security. Security headers such as Content-Security-Policy and X-Frame-Options are not explicitly detected and should be implemented to mitigate common web attacks. No incident response or security policy pages were found, which could enhance transparency and preparedness. No vulnerabilities or exposed sensitive data were detected in the HTML content. Overall, the security posture is good but could be strengthened with additional headers and published security policies.

Recommendations

  1. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  2. Implement and verify security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  3. Publish a dedicated security policy and incident response contact information to improve transparency and readiness.
  4. Add a vulnerability disclosure or security.txt file to facilitate responsible reporting of security issues.
  5. Regularly review and update third-party libraries and scripts to avoid vulnerabilities.

Contact details published on the site

Addresses
Legal name
Solis BioDyne OÜ
VAT number
EE100587614
Registration number
10242922
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Solis BioDyne OÜ
Description
Solis BioDyne develops and produces life science reagents since 1995, specializing in PCR, qPCR, RT-qPCR, and isothermal amplification reagents. They serve research institutes and biotech companies worldwide with high-quality molecular biology products.
Key services
Manufacturing and supply of PCR and qPCR reagents, Contract manufacturing, Product development, Assay development, White labeling
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, Bootstrap, Google Tag Manager, Google Analytics, LinkedIn Insight Tag, reCAPTCHA v3, Owl Carousel, Revolution Slider
Frameworks
Bootstrap
Platforms
Microsoft Online DNS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Use of Google reCAPTCHA v3
  • Cookie consent banner
  • No exposed sensitive data in HTML
  • Use of clientTransferProhibited domain status

Analytics and tracking

Services
Google Analytics, LinkedIn Insight, Mailchimp Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
LinkedIn Insight
Marketing tools
LinkedIn Insight, Mailchimp
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed with comprehensive product and company information
  2. Strong focus on PCR and molecular biology reagents with global customer base
  3. Good use of modern web technologies and analytics tools
  4. Privacy and cookie policies are present and GDPR compliant
  5. No signs of blocking or WAF interference
  6. Domain registration data supports legitimacy and long-term operation
  7. Certifications ISO 13485 and ISO 9001 reinforce quality and compliance
  8. Contact information is complete and clearly presented
Technical notes

Notes

The website is built on a modern technology stack featuring jQuery, Bootstrap, and advanced slider and carousel plugins. It integrates Google Tag Manager, Google Analytics, LinkedIn Insight, and Mailchimp for marketing and analytics purposes. The site is mobile responsive with good navigation clarity and SEO optimization. Hosting details are not explicit but DNS is managed via Microsoft Online name servers. Performance is moderate with asynchronous loading of scripts and optimized images. Accessibility is basic but could be improved with ARIA roles and enhanced keyboard navigation. The site uses reCAPTCHA v3 for bot protection and a cookie consent banner for privacy compliance. Overall, the technical infrastructure supports a professional and user-friendly experience with room for security and accessibility enhancements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with sbd.ee. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review sbd.ee.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.